Beirut, Lebanon

Namir Sioufi

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Profile: Namir Sioufi

Introduction

Namir Sioufi is an innovative inventor based in Beirut, Lebanon. He has made significant contributions to the field of biopharmaceuticals through his patented invention, which focuses on novel methods for assessing the bioactivity of oligomeric compounds.

Latest Patents

Namir Sioufi holds one patent titled "Conjugates for use in hepatocyte free uptake assays." This invention provides methodologies for identifying oligomeric compounds, such as siRNA and double-stranded RNA compounds, that exhibit biological activity in vivo. Additionally, his patent includes the development of specialized kits designed to facilitate these assays.

Career Highlights

Namir works at Isis Pharmaceuticals, Inc., a prominent entity in the biopharmaceutical sector known for its contributions to drug discovery and development. His role allows him to utilize his expertise in innovative assay technologies that advance therapeutic research.

Collaborations

Throughout his career, Namir has collaborated with notable colleagues, including C. Frank Bennett and Robert McKay. These partnerships have fostered a dynamic work environment that encourages the exchange of ideas and enhances the innovation process within the company.

Conclusion

Namir Sioufi exemplifies the essence of innovation in the pharmaceutical industry. His dedication to research and development is evident in his patented work, which has the potential to improve the assessment of bioactive compounds. Through his collaborations and ongoing efforts at Isis Pharmaceuticals, Namir continues to contribute to the advancement of biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…